Weiss Asset Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-166,611
Closed -$1.71M 617
2022
Q4
$1.71M Sell
166,611
-75,000
-31% -$762K 0.07% 256
2022
Q3
$2.43M Hold
241,611
0.06% 366
2022
Q2
$2.42M Hold
241,611
0.06% 348
2022
Q1
$2.42M Hold
241,611
0.05% 403
2021
Q4
$2.39M Buy
+241,611
New +$2.39M 0.05% 418

Other funds holding IQMD

Weiss Asset Management's IQMD Position: Q1 2023 in Review

Weiss Asset Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 166,611 shares — an estimated $1.71M sold.

Weiss Asset Management first reported a position in IQMD in Q4 2021 and held it in 5 quarters. The position peaked at $2.43M in Q3 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

  • Weiss Asset Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Weiss Asset Management sold 166,611 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $1.71M.
  • Weiss Asset Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
  • Weiss Asset Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $2.43M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Weiss Asset Management's 13F filing for Q1 2023, filed 10 May 2023.